Clinical Trial Update: Comparison of Thromboembolic Events in Patients Undergoing Thromboprophylactic Treatment With ENOXA® vs Lovenox® [Phase 4]

View source ↗

Summary

Phase 4 trial comparing thromboembolic events between ENOXA and Lovenox for thromboprophylaxis in patients with gastrointestinal neoplasms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Neoplasms

Drugs mentioned

• ENOXA
• Lovenox (enoxaparin)

Snippet

Sponsor: Les Laboratoires des Médicaments Stériles | Conditions: Gastrointestinal Neoplasms, Thromboembolic Event | Phase 4 | Status: COMPLETED